This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Gay, F. Articles by Salbert, G. Search for Related Content PubMed PubMed Citation Articles by Gay, F. Articles by Salbert, G.

The LIM/Homeodomain Protein Islet-1 Modulates Estrogen Receptor Functions

Equipe Information et Programmation Cellulaire (F.G., G.S.) and Equipe Endocrinologie Moléculaire de la Reproduction (I.A.) UMR 6026 Centre Nationale de la Recherche Scientifique Université de Rennes I, Campus de Beaulieu 35042 Rennes cedex, France
Department of Biological Sciences (Z.G.) National University of Singapore Singapore 119260

LIM/Homeodomain (HD) proteins are classically considered as major transcriptional regulators which, in cooperation with other transcription factors, play critical roles in the developing nervous system. Among LIM/HD proteins, Islet-1 (ISL1) is the earliest known marker of motoneuron differentiation and has been extensively studied in this context. However, ISL1 expression is not restricted to developing motoneurons. In both embryonic and adult central nervous system of rodent and fish, ISL1 is found in discrete brain areas known to express the estrogen receptor (ER). These observations led us to postulate the possible involvement of ISL1 in the control of brain functions by steroid hormones. Dual immunohistochemistry for ISL1 and ER provided evidence for ISL1-ER coexpression by the same neuronal subpopulation within the rat hypothalamic arcuate nucleus. The relationship between ER and ISL1 was further analyzed at the molecular level and we could show that 1) ISL1 directly interacts in vivo and in vitro with the rat ER, as well as with various other nuclear receptors; 2) ISL1-ER interaction is mediated, at least in part, by the ligand binding domain of ER and is significantly strengthened by estradiol; 3) as a consequence, ISL1 prevents ER dimerization in solution, thus leading to a strong and specific inhibition of ER DNA binding activity; 4) ISL1, via its N-terminal LIM domains, specifically inhibits the ER-driven transcriptional activation in some promoter contexts, while ER can serve as a coactivator for ISL1 in other promoter contexts. Taken together, these data suggest that ISL1-ER cross-talk could differentially regulate the expression of ER and ISL1 target genes.

This article has been cited by other articles:

				P. S. Quadros and C. K. Wagner Regulation of Progesterone Receptor Expression by Estradiol Is Dependent on Age, Sex and Region in the Rat Brain Endocrinology, June 1, 2008; 149(6): 3054 - 3061. [Abstract] [Full Text] [PDF]

				A. Hao, V. Novotny-Diermayr, W. Bian, B. Lin, C. P. Lim, N. Jing, and X. Cao The LIM/Homeodomain Protein Islet1 Recruits Janus Tyrosine Kinases and Signal Transducer and Activator of Transcription 3 and Stimulates Their Activities Mol. Biol. Cell, April 1, 2005; 16(4): 1569 - 1583. [Abstract] [Full Text] [PDF]

				A. M. Davis, M. L. Seney, H. J. Walker, and S. A. Tobet Differential Colocalization of Islet-1 and Estrogen Receptor {alpha} in the Murine Preoptic Area and Hypothalamus during Development Endocrinology, January 1, 2004; 145(1): 360 - 366. [Abstract] [Full Text] [PDF]

				J. Eeckhoute, B. Oxombre, P. Formstecher, P. Lefebvre, and B. Laine Critical role of charged residues in helix 7 of the ligand binding domain in Hepatocyte Nuclear Factor 4{alpha} dimerisation and transcriptional activity Nucleic Acids Res., November 15, 2003; 31(22): 6640 - 6650. [Abstract] [Full Text] [PDF]

				V. Y. Lin, E. M. Resnick, and M. A. Shupnik Truncated Estrogen Receptor Product-1 Stimulates Estrogen Receptor {alpha} Transcriptional Activity by Titration of Repressor Proteins J. Biol. Chem., October 3, 2003; 278(40): 38125 - 38131. [Abstract] [Full Text] [PDF]

				D. A. Schreihofer, D. F. Rowe, E. F. Rissman, E. M. Scordalakes, J.-a. Gustafsson, and M. A. Shupnik Estrogen Receptor-{alpha} (ER{alpha}), But Not ER{beta}, Modulates Estrogen Stimulation of the ER{alpha}-Truncated Variant, TERP-1 Endocrinology, November 1, 2002; 143(11): 4196 - 4202. [Abstract] [Full Text] [PDF]

				G.C. Weston, I. Haviv, and P.A.W. Rogers Microarray analysis of VEGF-responsive genes in myometrial endothelial cells Mol. Hum. Reprod., September 1, 2002; 8(9): 855 - 863. [Abstract] [Full Text] [PDF]

				T. Barkhem, L.-A. Haldosen, J.-A. Gustafsson, and S. Nilsson pS2 Gene Expression in HepG2 cells: Complex Regulation through Crosstalk between the Estrogen Receptor alpha , an Estrogen-Responsive Element, and the Activator Protein 1 Response Element Mol. Pharmacol., June 1, 2002; 61(6): 1273 - 1283. [Abstract] [Full Text] [PDF]

				C. M. Klinge, S. C. Jernigan, and K. E. Risinger The Agonist Activity of Tamoxifen Is Inhibited by the Short Heterodimer Partner Orphan Nuclear Receptor in Human Endometrial Cancer Cells Endocrinology, March 1, 2002; 143(3): 853 - 867. [Abstract] [Full Text] [PDF]